Downloads: 193
Review Papers | Pharmacy | Volume 9 Issue 4, April 2020 | Pages: 1099 - 1102 | India
Review on Use of Hydroxychloroquine and Azithromycin in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Abstract: Coronavirus pandemic is currently a global public health emergency. No effective prophylactic or post-exposure therapy is currently available for COVID-19, although some have been tried. One of such drug is combination of Hydroxychloroquine and Azithromycin. Recent publication shows that Hydroxychloroquine sulphate treatment is significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by Azithromycin. However, there is limited information about the use of them in COVID-19.
Keywords: COVID-19, prophylactic, post-exposure, Hydroxychloroquine Sulphate, Azithromycin, viral load
How to Cite?: Amandeep Singh Rawat, Jyoti Kathait, "Review on Use of Hydroxychloroquine and Azithromycin in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)", Volume 9 Issue 4, April 2020, International Journal of Science and Research (IJSR), Pages: 1099-1102, https://www.ijsr.net/getabstract.php?paperid=SR20418163658, DOI: https://dx.doi.org/10.21275/SR20418163658